Literature DB >> 27031422

Mitogen-activated protein kinase phosphatase-1: function and regulation in bone and related tissues.

David T Broome1, Nabanita S Datta1.   

Abstract

In this review, we have highlighted work that has clearly demonstrated that mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), a negative regulator of MAPKs, is an important signaling mediator in bone, muscle, and fat tissue homeostasis and differentiation. Further, we examined recent studies with particular focus on MKP-1 overexpression or deletion and its impact on tissues connected to bone. We also summarized regulation of MKP-1 by known skeletal regulators like parathyroid hormone (PTH)/PTH-related peptide (PTHrP) and bone morphogenic proteins. MKP-1's integration into the pathophysiological state of osteoporosis, osteoarthritis, rheumatoid arthritis, obesity, and muscular dystrophy are examined to emphasize possible involvement of MKP-1 both at the molecular level and in disease complications such as sarcopenia- or diabetes-related osteoporosis. We predict that understanding the mechanism of MKP-1-mediated signaling in bone-muscle-fat crosstalk will be a key in coordinating their activities and developing therapeutics to improve clinical outcomes for diseases associated with advanced age.

Entities:  

Keywords:  Bone; MAPK phosphatase-1; fat; muscle; pathophysiology; signaling

Mesh:

Substances:

Year:  2016        PMID: 27031422     DOI: 10.3109/03008207.2015.1125480

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  6 in total

1.  Parathyroid Hormone-Related Peptide and Its Analog, Abaloparatide, Attenuate Lethal Myocardial Ischemia-Reperfusion Injury.

Authors:  Joseph Wider; Vishnu V R Undyala; Beate Lanske; Nabanita S Datta; Karin Przyklenk
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

Review 2.  Protein tyrosine phosphatases in skeletal development and diseases.

Authors:  Huiliang Yang; Lijun Wang; Christian Shigley; Wentian Yang
Journal:  Bone Res       Date:  2022-01-28       Impact factor: 13.567

3.  Ononin ameliorates inflammation and cartilage degradation in rat chondrocytes with IL-1β-induced osteoarthritis by downregulating the MAPK and NF-κB pathways.

Authors:  Fang Xu; Liang-Jun Zhao; Ting Liao; Zhao-Cong Li; Lei-Lei Wang; Pan-Yu Lin; Rui Jiang; Qing-Jun Wei
Journal:  BMC Complement Med Ther       Date:  2022-01-27

4.  Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis.

Authors:  Eleni Zengini; Konstantinos Hatzikotoulas; Ioanna Tachmazidou; Julia Steinberg; Fernando P Hartwig; Lorraine Southam; Sophie Hackinger; Cindy G Boer; Unnur Styrkarsdottir; Arthur Gilly; Daniel Suveges; Britt Killian; Thorvaldur Ingvarsson; Helgi Jonsson; George C Babis; Andrew McCaskie; Andre G Uitterlinden; Joyce B J van Meurs; Unnur Thorsteinsdottir; Kari Stefansson; George Davey Smith; Jeremy M Wilkinson; Eleftheria Zeggini
Journal:  Nat Genet       Date:  2018-03-20       Impact factor: 38.330

5.  Integrative genomics analysis of eQTL and GWAS summary data identifies PPP1CB as a novel bone mineral density risk genes.

Authors:  Yu Zhai; Lu Yu; Yang Shao; Jianwei Wang
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

6.  Improving Obesity and Insulin Resistance by Targeting Skeletal Muscle MKP-1.

Authors:  Anton M Bennett; Ahmed Lawan
Journal:  J Cell Signal       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.